BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,341,000 | -7.0% | 2,980,000 | -0.7% | 0.00% | -72.7% |
| Q3 2017 | $3,591,000 | +0.6% | 3,000,000 | 0.0% | 0.01% | -8.3% |
| Q2 2017 | $3,568,000 | -24.5% | 3,000,000 | -25.0% | 0.01% | -25.0% |
| Q1 2017 | $4,723,000 | +0.7% | 4,000,000 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $4,688,000 | -6.0% | 4,000,000 | 0.0% | 0.02% | -11.1% |
| Q3 2016 | $4,987,000 | +7.8% | 4,000,000 | 0.0% | 0.02% | +5.9% |
| Q2 2016 | $4,625,000 | -2.5% | 4,000,000 | 0.0% | 0.02% | -5.6% |
| Q1 2016 | $4,742,000 | -11.3% | 4,000,000 | 0.0% | 0.02% | -10.0% |
| Q4 2015 | $5,345,000 | -0.6% | 4,000,000 | 0.0% | 0.02% | -9.1% |
| Q3 2015 | $5,375,000 | -15.6% | 4,000,000 | 0.0% | 0.02% | -4.3% |
| Q2 2015 | $6,370,000 | +5.2% | 4,000,000 | 0.0% | 0.02% | +4.5% |
| Q1 2015 | $6,057,000 | +23.5% | 4,000,000 | 0.0% | 0.02% | +22.2% |
| Q4 2014 | $4,903,000 | +11.9% | 4,000,000 | 0.0% | 0.02% | +5.9% |
| Q3 2014 | $4,380,000 | +4.0% | 4,000,000 | 0.0% | 0.02% | +6.2% |
| Q2 2014 | $4,212,000 | -5.1% | 4,000,000 | 0.0% | 0.02% | -5.9% |
| Q1 2014 | $4,440,000 | – | 4,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |